Authors/Disclosures
|
Matthias Maschke, MD
(Bruederkrankenhaus Trier)
|
No disclosure on file |
|
Oezguer Yaldizli, MD
|
Dr. Yaldizli has nothing to disclose. |
|
Jan Drappatz, MD
(University of Pittsburgh Cancer Institute)
|
Dr. Drappatz has stock in Pfizer. Dr. Drappatz has stock in Vertex. Dr. Drappatz has stock in GSK. The institution of Dr. Drappatz has received research support from Servier. Dr. Drappatz has received publishing royalties from a publication relating to health care. |
|
|
No disclosure on file |
|
Breanna Caruso
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
H. C. Diener, MD, FAAN
(University Duisburg-Essen)
|
Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme. The institution of Dr. Diener has received research support from German Research Council. |
|
Mark Obermann, MD, FAAN
(Department of Neurology, Klinikum Weser-Egge)
|
No disclosure on file |